1. Introduction {#sec1-genes-11-00672}
===============

Congenital brain malformations in humans are caused by genetic variants, in utero infection, or other environmental factors. Dogs and cats are also occasionally diagnosed with congenital brain malformations (reviewed in \[[@B1-genes-11-00672]\]), which are noted as breed predispositions, familial aggregations, or sporadic cases, especially in dogs \[[@B2-genes-11-00672],[@B3-genes-11-00672],[@B4-genes-11-00672],[@B5-genes-11-00672],[@B6-genes-11-00672]\]. Congenital hydrocephalus is common in toy and brachycephalic dog breeds, such as the Maltese, Yorkshire terrier, Chihuahua, toy poodle and pug dogs \[[@B7-genes-11-00672]\]. Widespread in Cavalier King Charles Spaniels, Chiari-like malformation is a common cause of foramen magnum obstruction, and results in the secondary syringomyelia in dogs, characterized by the mismatch of size between the brain and the skull \[[@B8-genes-11-00672]\].

Similarly, high grades of brachycephaly in cats are also associated with malformations of the calvarial and facial bones, as well as dental malformations or respiratory abnormalities \[[@B9-genes-11-00672],[@B10-genes-11-00672],[@B11-genes-11-00672],[@B12-genes-11-00672]\]. A familial craniofacial malformation with meningoencephalocele has been recognized in Burmese cats \[[@B13-genes-11-00672]\], which is caused by *ALX Homeobox 1* (*ALX1*) variant \[[@B14-genes-11-00672]\]. However, feline brain malformations with (suspected) idiopathic nature are mostly reported as sporadic events \[[@B15-genes-11-00672],[@B16-genes-11-00672],[@B17-genes-11-00672],[@B18-genes-11-00672],[@B19-genes-11-00672],[@B20-genes-11-00672]\]. Overall, the genetic factors contributing to brain (mal) formation and structural congenital brain disease in dogs and cats are largely unknown.

In an effort to develop a breed of cats having similar phenotypes to a tiger, including a small rounded ear, a mixed breed cat derived from the Oriental cat breed was discovered to have small rounded ears and hence, was used as a foundation sire for a breeding program. Outcross and backcross breeding indicated the phenotype was autosomal recessive \[[@B21-genes-11-00672]\]. However, a magnetic resonance imaging (MRI) examination of a kitten with the desired ear phenotype, which had an accidental head injury from a fall, indicated the presence of congenital hydrocephalus. Additional MRIs of the breeding stock suggested cats with the ear phenotype had congenital brain malformations. These cats have small rounded ear pinnae and doming of the head ([Figure 1](#genes-11-00672-f001){ref-type="fig"}). This extended family of mixed-breed cats derived from the Oriental breed has been characterized clinically and histopathologically with forebrain commissural malformation concurrent with ventriculomegaly and interhemispheric cysts \[[@B21-genes-11-00672]\]. The forebrain malformations include dysgenesis of the septum pellucidum, interthalamic adhesion, and all the midline commissures, excluding the rostral white commissure, as well as hippocampal hypoplasia. Clinical symptoms include mild generalized ataxia when walking, and mild to marked postural reaction deficits, although cranial nerve examination and segmental reflexes are within normal limits. All the cats with neurological signs have midline and limbic structure abnormalities, dilated ventricles and hemispheral cysts with or without a suprapineal cyst. These findings resemble a mild variant of holoprosencephaly (HPE) in human (OMIM: 236,100 and others). Although variations in the severity of the forebrain commissural malformation were seen, most affected cats are hydrocephalic. No chromosomal abnormalities are noted in a karyotypic analysis of the cats. Segregation analysis suggests an autosomal recessive mode of inheritance; however, the causal variant remained unknown \[[@B21-genes-11-00672]\].

As a result of the potentially harmful impacts associated with the trait, the breeder promptly discontinued the breeding program and altered subsequent cats. However, some carriers for the trait had already been adopted for other breeding programs. A group of affected cats were presented to the researchers for pathological and genetic studies. Sample collection from the cats in the owner's breeding program and cats from controlled breeding within the university colony supported the genetic investigation of the abnormal brain development and mode of inheritance.

Genome-wide association studies (GWAS), using a sib-transmission disequilibrium test (sib-TDT) and a case-control analysis, and homozygosity mapping were conducted to detect an associated genomic region for the syndrome using genotypes from a feline single nucleotide polymorphism (SNP) DNA array \[[@B22-genes-11-00672]\]. Whole genome sequencing (WGS) was conducted on a cat trio segregating for the syndrome to define the location and identify candidate variants.

2. Materials and Methods {#sec2-genes-11-00672}
========================

2.1. Sampling and Pedigree {#sec2dot1-genes-11-00672}
--------------------------

All procedures were performed with an approved University of Missouri (MU) Institutional Animal Care and Use Committee protocol (ACUC protocol \# 8292). Four affected and two carrier cats were donated and housed at the MU colony for controlled breeding. Additional buccal swab and cadaver samples from an external breeding program were provided voluntarily by the breeder/owner (*N* = 129). DNA samples were extracted using DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA, USA). The quality of the DNA samples was visualized and confirmed by agarose gel electrophoresis. DNA samples whose concentration was insufficient were whole genome amplified, using the REPLI-g Mini Kit (Qiagen). The relationship of the ascertained cats was confirmed using short tandem repeat (STR) markers, as previously described \[[@B23-genes-11-00672]\]. Parentage analysis was performed using the computer program COLONY \[[@B24-genes-11-00672],[@B25-genes-11-00672]\]. Clinical and histopathological features of the syndrome were characterized previously \[[@B21-genes-11-00672]\]. Although some cats were phenotyped based on MRI and/or histopathology, most cats were assumed to have the brain malformation based on the ear morphology, since clinically healthy cats had elongated (normal) ears and clinically affected cats had the small, rounded ear type \[[@B21-genes-11-00672]\] ([Figure 1](#genes-11-00672-f001){ref-type="fig"}). Images or cadavers of cats were not always available.

2.2. DNA Array Genotyping {#sec2dot2-genes-11-00672}
-------------------------

Fifty-two genomic DNA samples (\~600 ng each) were submitted to GeneSeek (Neogene, Lincoln, NE, USA) for SNP genotyping on the Illumina Infinium Feline 63K iSelect DNA Array (Illumina, San Diego, CA, USA) \[[@B22-genes-11-00672]\]. The original SNP positions were based on an early assembly of the cat genome \[[@B26-genes-11-00672]\], and have been since relocalized to the latest feline genome assembly, Felis_catus_9.0. The SNP positions based on the Felis_catus_9.0 assembly were used for the analyses and the required map file is available. \[[@B27-genes-11-00672]\]. Quality control of the SNP data was performed using PLINK (v1.07) \[[@B28-genes-11-00672]\]. The following criteria were applied: (i) individuals with genotyping success rate of \<80% were removed (\--mind 0.2); (ii) SNP markers with a genotyping rate \<80% were removed (\--geno 0.2); and (iii) SNPs with a minor allele frequency of 0.05 or less were removed (\--maf 0.05). Furthermore, SNPs that were previously reported to have missing ≥10% of genotypes and Mendelian errors \[[@B22-genes-11-00672]\], and that remained after quality controls were excluded.

2.3. Genome-Wide Association Studies {#sec2dot3-genes-11-00672}
------------------------------------

After the SNP pruning described above, GWAS were conducted using PLINK. Sib-TDT \[[@B29-genes-11-00672]\] was performed using the DFAM procedure in PLINK (\--dfam). This method implements sib-TDT and also includes unrelated individuals in the analysis. A case-control association analysis was performed (\--assoc). The genomic inflation factor was calculated using the function (\--adjust). Multi-dimensional scaling (MDS) analysis was conducted (\--genome) and MDS plots were generated to visualize the population stratification, using PLINK and R software (version 3.3.3; R Foundation for Statistical Computing, Vienna, Austria), respectively. A quantile-quantile (QQ) plot was created using R. Genome-wide significance for both analyses, which was determined using 100,000 permutations (\--mperm 100000). Manhattan plots from the sib-TDT, case-control association and permutation analyses were generated using R. The MDS plot was used to reselect cats to minimize stratification between cases and controls for the secondary case-control association analysis, by visual interpretation.

2.4. Haplotype Analysis {#sec2dot4-genes-11-00672}
-----------------------

An approximately 6 Mb region surrounding highly associated SNPs was extracted, including 81 SNPs, from SNP chrA3.163737349 at chromosome position A3: 123,014,546 to SNP chrA3.156620632 at chromosome position A3: 128,837,125. The haplotype boundaries were visually confirmed using Haploview (version 4.2) \[[@B30-genes-11-00672]\]. Linkage disequilibrium (LD) blocks were identified using the solid spine of LD method in Haploview. Haplotype sequences are estimated using an accelerated EM algorithm, as implemented in Haploview. When analyzing LD blocks and haplotypes, SNPs with MAF of 0% were allowed and included, because most cases showed the consistent genotypes at each SNP.

2.5. Homozygosity Analysis {#sec2dot5-genes-11-00672}
--------------------------

Homozygosity analysis was performed using PLINK. SNPs within a 1000 kb window, containing at least 25, were investigated for runs of homozygosity (\--homozyg-window-kb 1000, \--homozyg-snp 25). In each window, five missing genotypes (20%) and a single heterozygote (2%) were tolerated (\--homozyg-window-missing 5, \--homozyg-window-het 1). The threshold of homozygosity match was set as 0.99 (\--homozyg-match 0.99). A homozygous block was characterized by five SNPs (\~200--250 kb). Consensus homozygosity blocks were identified as overlaps between individual homozygosity blocks (\--consensus-match, \--homozyg-group).

2.6. Whole Genome Sequencing {#sec2dot6-genes-11-00672}
----------------------------

A trio of cats including an affected sire, a carrier dam and an affected offspring was selected for WGS as part of the 99 Lives Cat Genome Sequencing Initiative (<http://felinegenetics.missouri.edu/99lives>). These cats were produced at the MU colony; thus, the parentage was known. DNA extraction and library preparation were conducted as previously described \[[@B31-genes-11-00672]\]. A minimum of 4 µg genomic DNA was submitted for WGS to the MU DNA Core Facility. Two PCR-free libraries with insertion sizes of 350 bp and 550 bp were constructed for each cat using the TruSeq DNA PCR Free library preparation kit (Illumina). The Illumina HiSeq 2000 (Illumina) was used to generate sequence data.

Sequence reads were mapped to the latest feline genome assembly, Felis_catus_9.0, and processed as previously described \[[@B27-genes-11-00672]\]. Briefly, read mapping was conducted with Burrows-Wheeler Aligner (BWA) version 0.7.17 \[[@B32-genes-11-00672]\]. Duplicates were marked using Picard tool MarkDuplicates (<http://broadinstitute.github.io/picard/>). Potential insertions or deletions (indels) realignment was performed using the Genome Analysis Tool Kit (GATK version 3.8) \[[@B33-genes-11-00672]\] IndelRealigner. Variants were called using GATK HaplotypeCaller in gVCF mode \[[@B34-genes-11-00672]\]. VarSeq v2.0.2 (Golden Helix, Bozeman, MT, USA) was used to annotate variants with Ensembl 99 gene annotations and identify variants unique to the trio cats and absent from 192 unaffected unrelated domestic cats. Exonic variants were extracted from the dataset, including variants 21 bp flanking the exons to ensure inclusion of variants that may affect splice donor and accept sites. Candidate variants segregating across the trio were visualized using Integrative Genomics Viewer (IGV) \[[@B35-genes-11-00672]\].

2.7. Variant Validation and Genotyping {#sec2dot7-genes-11-00672}
--------------------------------------

PCR and Sanger sequencing were performed to validate the 7 bp deletion in the candidate gene *GDF7* for cats that were submitted to WGS. The primer sequences were: forward primer: 5′-AGCGACATCATGAACTGGTG-3′, reverse primer: 5′-CCACGGAGCCCATGGACC-3′. PCR was performed using AccuPrime GC-Rich DNA Polymerase (Invitrogen, Carlsbad, CA, USA). PCR was performed following the manufacturer's instructions, with the annealing temperature of 61 °C and 35 cycles. PCR amplicon was purified using QIAquick Gel Extraction Kit (Qiagen), or using ExoSAP-IT PCR Product Cleanup Reagent (Thermo Fisher Scientific, Waltham, MA, USA). Sanger sequencing was conducted at the MU DNA Core Facility using an Applied Biosystems 3730xl DNA Analyzer (Applied Biosystems, Foster City, CA, USA) with BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems).

Fragment analysis was conducted for population screening. PCR conditions and reagents used were the same as above, except the forward primer was fluorescein amidite \[FAM\] labeled at the 5′ end. Fragment analysis was conducted at the MU DNA Core Facility using an Applied Biosystems 3730xl DNA Analyzer (Applied Biosystems). The expected wildtype fragment size was 294 bp, while the mutant fragment size was expected as 287 bp. Amplicons were analyzed using STRand software \[[@B36-genes-11-00672]\].

3. Results {#sec3-genes-11-00672}
==========

3.1. Pedigree and Genotyping {#sec3dot1-genes-11-00672}
----------------------------

Using 18 STRs, the parentage for 69 of 129 cats was determined with a high likelihood using the COLONY software \[[@B24-genes-11-00672],[@B25-genes-11-00672]\] (data not shown), producing a pedigree of 79 cats ([Figure S1](#app1-genes-11-00672){ref-type="app"}). For GWAS, 52 cats were selected using owner provided and pedigree information, including 26 cases, and 26 controls, in which 43 cats were included in the pedigree ([Figure S1](#app1-genes-11-00672){ref-type="app"}). Cat DNA samples were genotyped on Feline 63K SNP array ([File S1](#app1-genes-11-00672){ref-type="app"}). Selection criteria for genotyping focused on cats that were as unrelated as possible. Nine cats with call rates below 80% were removed, and 478 SNPs were removed with missingness rates \> 20%. An additional 22,297 SNPs were also removed with minor allele frequencies \< 0.05. After filtering, 20 cases and 23 controls remained with a genotyping rate of 0.977 across 40,263 SNPs. Furthermore, 372 SNPs were excluded, due to missing ≥10% of genotypes and Mendelian errors previously reported \[[@B22-genes-11-00672]\]. The GWAS was conducted with 39,891 SNPs.

3.2. Association Studies {#sec3dot2-genes-11-00672}
------------------------

Sib-TDT was conducted on the pedigree formed by the 20 cases and 23 controls. After permutation testing, no SNPs were significant; however, nine SNPs with the highest, the second-highest, or the third-highest association were localized to cat chromosome A3:123,055,238--128,667,138 on the Felis_catus_9.0, extending approximately 5.6 Mb ([Table 1](#genes-11-00672-t001){ref-type="table"}). The result of the sib-TDT analysis was presented as a Manhattan plot ([Figure 2](#genes-11-00672-f002){ref-type="fig"}a). In the initial case-control association analysis, 65 SNPs had genome-wide significance and were located cat chromosome A3: 116,714,934--129,668,450, extending \~13.0 Mb and C1: 105,429,018--115,412,315, extending \~10.0 Mb ([Table 1](#genes-11-00672-t001){ref-type="table"}). However, the genomic inflation factor was 1.89; thus, the MDS plot ([Figure S2](#app1-genes-11-00672){ref-type="app"}) was used to reselect cases and controls for the analysis. A second case-control association analysis was performed with 14 cases and nine controls, and the genomic inflation factor was reduced to one. Seventeen SNPs showed genome-wide significance and were located cat chromosome A3: 119,105,247--129,372,537, encompassing \~10.3 Mb ([Figure 2](#genes-11-00672-f002){ref-type="fig"}b, [Table 1](#genes-11-00672-t001){ref-type="table"}). This chromosome A3 region encompassed the entire region suggested by the sib-TDT, and was within the initial case-control association analysis.

3.3. Haplotype Analysis {#sec3dot3-genes-11-00672}
-----------------------

The 6 Mb region, on chrA3: from approximately 123 to 129 Mb and encompassing the overlapped region identified in GWAS, was visually inspected for common haplotypes using Haploview. In affected cats, a large extended LD block encompassing approximately 4.3 Mb (A3: 123,082,369--127,348,216) was identified with a 95% frequency of the sequential haplotype. Considering that two cats had 82.7% and 91.4% genotyping rate, one cat had 98.8% and the others had 100% genotyping rate in this area, a few missing produced the remaining haplotypes ([File S2](#app1-genes-11-00672){ref-type="app"}). Short and discontinuous LD blocks are identified by Haploview in controls. There are various haplotype sequences and frequencies approximately within the 6 Mb regions in unaffected cats.

3.4. Homozygosity Analysis {#sec3dot4-genes-11-00672}
--------------------------

Homozygosity mapping was performed on 20 cases and 23 controls. The homozygosity analysis identified the same location on chromosome A3 in 18 of 20 affected cats, excluding the same two cases that did not have sufficiently high genotyping rates, with A3: 125,601,560--127,684,693, spanning approximately 2.1 Mb, and no unaffected cats were homozygosity ([Table S1](#app1-genes-11-00672){ref-type="app"}). The region was identified by the two genome-wide association analyses ([Table 1](#genes-11-00672-t001){ref-type="table"}). Although other ROHs were identified, none were specific to cases or as extensive.

3.5. Whole Genome Sequencing {#sec3dot5-genes-11-00672}
----------------------------

Cat genomes have been submitted to the NCBI short read archive under BioProject: PRJNA528515; Accessions PRJNA343385; SRX2654400 (Sire), SRX2654398 (dam) and SRX2654399 (offspring). Genome sequence analyses and variant calling for the 99 Lives project has been previously described \[[@B37-genes-11-00672]\]. Approximately 2.5 million variants were ascertained across 195 cats in the exonic portion of the dataset, which included 21 bp of exon flank sequence. No candidate genes were identified on cat chromosome A3 during the initial analysis, when considering the sire and offspring to be homozygous affected, and considering the dam as an obligate carrier for an alternative allele ([Table 2](#genes-11-00672-t002){ref-type="table"}). Only an intergenic variant (C1:106,990,675) and an intronic variant in *sperm antigen with calponin homology and coiled-coil domains* (*SPECC1*) (E1:9,973,078) met the segregation criteria. Using relaxed constraints, where affected cats were allowed to also be considered as carriers, four more variants were identified (C1:96,095,693, C1:96,839,645 and D2:33,368,378) with only one variant located within the critical region and also in a gene coding region ([Table 2](#genes-11-00672-t002){ref-type="table"}). This variant was a 7 bp deletion in the coding region of *GDF7* (c.221_227delGCCGCGC \[p.Arg74Profs\*17\]) at the position A3:127002233 (ENSFCAT00000063603). The variant was identified as homozygous in the affected sire, heterozygous in the obligate carrier dam, heterozygous in the affected offspring, and absent from the other 192 domestic cats. Although each cat in the trio had an average of \~30× genome coverage, the sire had 18× coverage within the region, the dam had \~14× coverage with seven reads per allele, and the affected offspring had \~16× coverage, with only one of the reads representing the reference allele, likely misrepresenting the offspring as heterozygous, and visual inspection with IGV suggested the affected offspring was instead very likely homozygous for the variant ([Figure 3](#genes-11-00672-f003){ref-type="fig"}). The affected cat was confirmed as a homozygote for the alternate allele by genotyping. The *GDF7* variant was predicted to cause a truncated protein with 89 amino acids, while the wildtype protein has 455 amino acids ([Figure S3](#app1-genes-11-00672){ref-type="app"}). Feline *GDF7* amino acid sequence is predicted to be 86.2%, 90.1%, 84.6%, 77.8% and 77.2% identical to human, horse, cow, rat and mouse, respectively ([Figure S3](#app1-genes-11-00672){ref-type="app"}). In addition, comparison of the *GDF7* locus between the Felis_catus_9.0 and Felis_catus_8.0 genome assemblies, revealed the region containing the *GDF7* candidate variant is absent from the Felis_catus_8.0 assembly, indicating the importance of the updated reference genome for trait discovery.

3.6. Variant Validation and Genotyping {#sec3dot6-genes-11-00672}
--------------------------------------

Sanger sequencing was performed to confirm the identified *GDF7* c.221_227delGCCGCGC in affected and obligate carrier cats, including the cats in the WGS trio. The 7 bp deletion in *GDF7* was screened in 25 affected, 39 unaffected, and two cats with unknown phenotype in the extended pedigree using fragment analysis ([Figure S4](#app1-genes-11-00672){ref-type="app"}). Both unknown cats were homozygous for the variant allele. Overall, 13 of 14 suspected wildtype cats in the extended pedigree were concordant, and one cat genotyped as a heterozygote. Of 25 suspected carriers, 23 genotyped as heterozygote and two as wildtype normal. Of 22 suspected affected cats, 20 genotyped as homozygous for the variant, one as heterozygous and one as wildtype normal.

4. Discussion {#sec4-genes-11-00672}
=============

Brain malformations are occasionally identified in veterinary practice. However, little is known about the genetic causes and interactions for brain malformation. Due to the health concerns associated with breed development, particularly in dog breeds \[[@B38-genes-11-00672],[@B39-genes-11-00672]\], many breeders have become more vigilant to health-associated consequences of selection based on morphological phenotypes. Feline brain malformation syndrome seen in this extended family happened to be generated in the course of breeding selection for the ear morphological phenotype.

Most of the cat samples had been archived as frozen cadavers by the breeder, and later provided to the researchers. As a result of poor documentation of relationships and disease status, a pedigree was established by determining parentage using STRs, age, and gender of the cats and from interviews with the breeder. Ear phenotypes, which were used as a proxy for disease, were difficult to determine from frozen cadavers. Due to the significant inbreeding and backcrossing required to maintain the phenotype, 18 STRs were often insufficient to determine parentage. However, some known breedings were available from the university colony. Overall, an extended pedigree was developed, and was expected to be sufficient for GWAS and WGS investigations for the causal variant. Furthermore, a variant dataset from WGS of domestic cats, the 99 Lives Cat Genome Sequencing Initiative, which has revealed the causative variants for several cat diseases and traits in the last several years \[[@B31-genes-11-00672],[@B40-genes-11-00672],[@B41-genes-11-00672],[@B42-genes-11-00672],[@B43-genes-11-00672],[@B44-genes-11-00672],[@B45-genes-11-00672],[@B46-genes-11-00672]\], was considered to facilitate the variant filtering to find the private variants.

In humans, HPE is the most common malformation of the prosencephalon, and its prevalence is approximate 1 in 10,000 births \[[@B47-genes-11-00672]\]. A common feature of HPE includes the incomplete separation of the anterior part of the forebrain or telencephalon. The previous study indicated this feline heritable brain malformation syndrome resembled a mild form of HPE \[[@B21-genes-11-00672]\]. Many genes have been reported to cause HPE in humans (reviewed in \[[@B48-genes-11-00672],[@B49-genes-11-00672],[@B50-genes-11-00672]\]). However, *GDF7*, also known as *bone morphogenetic protein 12* (*BMP12*), has not been reported to be associated with HPE in humans. Initially, *GDF7* activity was shown to be required for the specification of neuronal identity in the spinal cord \[[@B51-genes-11-00672]\]. *GDF7* mRNA is expressed within the roof plate, when commissural axons initiate to grow ventrally-directed. Furthermore, *GDF7*-null mutant mice show hydrocephalus, and they show considerable variation in the location of the dilated ventricle \[[@B51-genes-11-00672]\]. This evidence supports these findings that the frameshift mutation in *GDF7* causing the truncated protein is highly likely to be associated with this heritable brain malformation syndrome in cats. Transcriptomic and proteomic analyses would be essential to ascertain that this *GDF7* variant causes heritable forebrain commissural malformation in cats.

The variable severity of this syndrome in the cat pedigree was reported previously \[[@B21-genes-11-00672]\]. In humans, heterogeneity in familial HPE is also identified even if different individuals are carrying the same mutation \[[@B52-genes-11-00672],[@B53-genes-11-00672],[@B54-genes-11-00672]\]. The influence of environmental or teratogenic factors or modifier genes have been suggested for the spectrum (reviewed in \[[@B47-genes-11-00672],[@B48-genes-11-00672],[@B50-genes-11-00672]\]). Assuming no exposure to teratogen and relatively homogeneous living environment, the presence of modifier genes is suspected for the variable severity of the dilated ventricles and supratentorial cysts in cats presented here.

Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-β (TGF-β) superfamily of proteins that are involved in many functions such as cell proliferation, differentiation, apoptosis, cell fate determination and morphogenesis \[[@B55-genes-11-00672]\]. The BMPs also play various roles in the neural development \[[@B56-genes-11-00672]\]. Among them, *GDF7* also known as BMP12, plays an essential role in bone and cartilage formation as well \[[@B57-genes-11-00672]\]. Except for hydrocephalus seen in *GDF7*-null mutant mice \[[@B51-genes-11-00672]\], several phenotypes caused by *GDF7* deficient mice have been reported, including the subtle effect on Achilles tendon \[[@B58-genes-11-00672]\], increased endochondral bone growth \[[@B59-genes-11-00672]\], seminal vesicle defects and sterility \[[@B60-genes-11-00672]\], and smaller bone cross-sectional geometric parameters \[[@B61-genes-11-00672]\]. In addition, a variant in *GDF7* (rs3072) has been reported to increase risk for Barrett's esophagus and esophageal adenocarcinoma \[[@B62-genes-11-00672],[@B63-genes-11-00672]\]. Although, to the authors' knowledge, there was no report about the involvement of *GDF7* in ear or skull morphology, there is a possibility that small rounded pinnae and/or domed craniums may be influenced by the *GDF7* variant, because *GDF7*, also known as BMP12, has been considered to play a negative role on chondrogenesis \[[@B59-genes-11-00672]\], and to be involved in the structural integrity of bone \[[@B61-genes-11-00672]\].

In conclusion, the combination of GWAS, homozygosity mapping and WGS identified a 7 bp deletion in *GDF7* (c.221_227delGCCGCGC), which is the most likely variant causing feline forebrain commissural malformation, concurrent with ventriculomegaly and interhemispheric cysts in this domestic cat lineage, although the functional analysis has not been achieved to prove the deterministic mechanism. Furthermore, this study highlights the importance of *GDF7* in the neurodevelopmental course in cats, and brings new insight into neurodevelopmental biology. Cat breeders can now perform a genetic test to eradicate the *GDF7* mutation from the breeding population.
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The following are available online at <https://www.mdpi.com/2073-4425/11/6/672/s1>. Table S1: Regions of homozygosity was unique to 18 cats with the inherited forebrain commissural malformation, and were absent in all the unaffected cats. Figure S1: Pedigree of cats segregating for an autosomal recessive forebrain commissural malformation. Relationships of 79 cats (27 nuclear families) provided by the breeder and confirmed with genetic testing of short tandem repeats when possible. Arrow indicates the proband. Circles indicate females, squares indicate males, and diamonds indicate unknown sex. Filled symbols represent cats with small rounded ears, which were suspected to have forebrain commissural malformation concurrent with ventriculomegaly and interhemispheric cysts. Half-filled represent obligate carriers. Symbols with question marks represent cats with unknown phenotype. A symbol with no fill indicates the cat is known to be completely unrelated and not expected to be a carrier. The cats genotyped on the DNA array and used for genome-wide association studies and homozygosity mapping are indicated by a "T" on the upper left of the symbol (The nine cats removed by quality control are not indicated). A black filled circle at the left bottom of symbol are individuals that were whole genome sequenced. Cats with a bar above the symbol were confirmed by magnetic resonance imaging. Cats with an open circle to the upper right had histology performed at necropsy. The cats' ID/name is indicated below the symbol. Size in basepairs of the genotypes for the 7 bp *GDF7* indel are indicated below each cat available. Figure S2: Multi-dimensional scaling plot and quantile-quantile plot of cases and controls for genome-association analyses. (a) Multi-dimensional scaling (MDS) plot of cats used for the initial case-control association analysis. The genomic inflation was 1.89. Therefore, cats clustered within the blue rectangular area were selected for the second case-control association analysis as visual inspection suggests less stratification between cases and controls. The genomic inflation factor was reduced to 1. (b,c) The quantile-quantile plots of cats used for the initial (b) and second (c) analyses demonstrate the observed versus expected--log(p) values. Figure S3: Protein sequence alignment of *GDF7* in cats (*Felis catus*) and other species. GDF7 protein sequences are aligned from wildtype cat (*Felis catus*), *GDF7* mutant cat, cow *(Bos Taurus*: NP_001193030.1 \[ARS-UCD1.2\]), horse (*Equus caballus*: XP_023475218.1 \[EquCab3.0\]), mouse (*Mus musculus*: NP_001299805.1 \[GRCm38.p4\]), and rat (*Rattus norvegicus*: XP_006239940.1 \[Rnor_6.0\]). Identical amino acids to those of Felis catus sequence are represented as a dot (.). Deleted amino acids are represented as a dash (--). A 7 bp deletion causes a frameshift and changes the amino acid sequence from 74th position (highlighted in yellow), starting with an arginine to a proline change, which results in the truncated protein with a stop codon 17 amino acids downstream. Figure S4. Variant validation by Sanger sequencing and fragment analysis. (a) Sanger sequence of a wildtype and homozygous affected cat for the 7 bp *GDF7* variant (boxed region). (b) Fluorescence-based fragment analysis using an ABI 3730XL for the *GDF7* variant. Left---homozygous wildtype with 294 bp fragment, middle---heterozygous with 287 and 294 bp fragments, and right---affected with 287 bp fragment. LIZ standard (Applied Biosystems, Foster City, CA, USA) was used to size DNA fragments. File S1: Ped file for PLINK of cats genotyped using Illumina Infinium Feline 63K iSelect DNA Array. File S2: SNPs (*n* = 81) forming common haplotype for cats in the association studies.

###### 

Click here for additional data file.
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![Domestic cats with heritable forebrain commissural malformation. Note the abnormal presentation of the pinnae used to determine affection status. (**a**) Frank---affected sire (left). (**b**) Camilla---carrier dam. (**c**) Bobble---affected offspring. These three cats (**a**--**c**) were whole genome sequenced. (**d**) Transverse plane of T2-weighted magnetic resonance imaging of an affected cat at the level of the thalamus. Severe ventriculomegaly, thinning of the cerebral parenchyma and midline structure deficits are seen. A part of the parietal lobe is deficient. (**e**) Mid-sagittal plane of T2-weighted magnetic resonance imaging of an affected cat (the same cat as (**d**)). Midline structure deficits are recognized. Note that the spinal cord is formed normally. Interhemispheric cysts are also seen at the rostrotentorial region and the quadrigeminal cistern. Due to the presence of cysts, cerebellar herniation is seen. (**f**) Gross dorsal view of the dissected head at necropsy. The skin was removed, and the skull was exposed. (**g**) Transverse sections of formalin-fixed brain tissue at the level of frontal lobe and thalamus. Severe ventriculomegaly, thinning of the cerebral parenchyma and midline structure deficits are seen. Note that a cat whose magnetic resonance imaging of (**d**) and (**e**) are presented here is different from cats whose gross pathological pictures of (**f**) and (**g**) are provided here.](genes-11-00672-g001){#genes-11-00672-f001}

![Manhattan plot of the genome-wide association studies (GWAS) for heritable forebrain commissural malformation in cats. Cats (20 cases and 23 controls) were genotyped on the Illumina Infinium Feline 63K iSelect DNA Array (Illumina, San Diego, CA, USA) and used for GWAS. In both panels of (**a**) and (**b**), the upper plots exhibit the *P~raw~* value of the analysis, while the lower exhibits the *P~genome~* values after 100,000 permutations. Red horizontal lines indicate genome-wide significance (*P~genome~* = 0.05, −log~10~ = 1.3). (**a**) Sib-TDT analysis. Genome-wide significance was not achieved. (**b**) Case-control association analysis. Significant association is localized to chromosome A3 for 17 SNPs. The genomic inflation was 1.](genes-11-00672-g002){#genes-11-00672-f002}

![Depiction of the whole genome sequence reads using the Integrated Genome Viewer (IGV) of (**a**) affected sire, (**b**) carrier dam, and (**c**) affected offspring for the *GDF7* variant. Grey horizontal bars represent individual reads, while grey vertical bars at the top of each sub figure represent depth of coverage. Notice in affected individuals (**a**,**c**), coverage is close to zero in the deleted region, while, in the carrier sequencing (**b**), coverage is approximately 50%. Additionally, in affected individuals (**a**,**c**), reads with high numbers of mismatches are indicative of the misidentification of an indel, and tend to occur near the ends of reads.](genes-11-00672-g003){#genes-11-00672-f003}
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###### 

Single nucleotide polymorphism (SNP) associations for cats with heritable forebrain commissural malformation in the sib-transmission disequilibrium test (sib-TDT) and case-control association analyses.

  SNP \*            Chr   Position ^†^   Sib-TDT   Case-Control (Initial)   Case-Control (2nd)
  ----------------- ----- -------------- --------- ------------------------ --------------------
  chrA3.164724433   A3    123353491      \>0.6     0.0001                   0.0045
  chrA3.164567500   A3    122318611      \>0.6     0.0001                   0.0045
  chrA3.164340161   A3    122513677      \>0.6     0.0001                   0.0045
  chrA3.164113252   A3    122698750      \>0.6     0.0001                   0.0045
  chrA3.163320257   A3    123353491      0.5639    0.0001                   0.0045
  chrA3.162970354   A3    123644765      \>0.6     0.0001                   0.0045
  chrA3.162343840   A3    124176474      \>0.6     0.0004                   0.0045
  chrA3.158624618   A3    127189752      \>0.6     0.0001                   0.0045
  chrA3.159621145   A3    126377299      0.5639    0.0001                   0.0082
  chrA3.162413594   A3    124100380      \>0.6     0.0014                   0.0137
  chrA3.156826206   A3    128667138      0.5639    0.0001                   0.0169
  chrA3.156620632   A3    128837125      \>0.6     0.0001                   0.0169
  chrA3.155936886   A3    129372537      \>0.6     0.0004                   0.0169
  chrA3.168960567   A3    119105247      \>0.6     0.0128                   0.0261
  chrA3.168031908   A3    119810207      \>0.6     0.0264                   0.0261
  chrA3.167492986   A3    120088757      \>0.6     0.0061                   0.0261
  chrA3.167322483   A3    120215597      \>0.6     0.0292                   0.0261
  chrA3.162621987   A3    123934341      0.5521    0.0014                   \>0.05
  chrA3.163679766   A3    123055238      0.5639    0.0004                   \>0.05
  chrA3.161984351   A3    124475589      0.5639    0.0002                   \>0.05
  chrA3.161943004   A3    124509146      0.5639    0.0002                   \>0.05
  chrA3.161399869   A3    124945294      0.5639    0.0020                   \>0.05
  chrA3.160673309   A3    125511595      0.5639    0.0002                   \>0.05

*p*-values were presented with up to four decimal places. \* SNP IDs are based on an early cat genome assembly \[[@B26-genes-11-00672]\] ^†^ Positions based on current cat genome assembly \[[@B27-genes-11-00672]\].
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###### 

Variants identified in 99 Lives whole genome sequence dataset considering segregation within the trio.

  ---------------------------------------------------------------------------------------------------------------------------
  Chr:Pos        Ref/Alt     No. Het \*   No. Homo   Gene Name   Sequence Ontology   Effect   HGVS c. (Clinically Relevant)
  -------------- ----------- ------------ ---------- ----------- ------------------- -------- -------------------------------
  A3:127002233   GCGCGGC/-   2            1          *GDF7*      frameshift          LoF      ENSFCAT00000063603:\
                                                                                              c.221_227delGCCGCGC

  C1:96095693    C/T         2            1                      intergenic          Other    

  C1:96839645    C/T         2            1                      intergenic          Other    

  D2:33368378    C/A         2            1                      intergenic          Other    

  C1:106990675   C/A         1            2                      intergenic          Other    

  E1:9973078     C/T         1            2          *SPECC1*    Intron              Other    ENSFCAT00000005195:\
                                                                                              c.2850 + 13572G \> A
  ---------------------------------------------------------------------------------------------------------------------------

\* Only the dam should be heterozygous for the variant in the dataset and the sire and offspring homozygous for the variant. Sequence data was poor within the critical region on cat Chromosome A3, and the affected offspring was erroneously considered heterozygous by the Genome Analysis Tool Kit (GATK version 3.8). Four variants are identified when the offspring is considered heterozygous.
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